MEDTECH INDUSTRY INVITED TO NSW PARLIAMENT HOUSE Local manufacturing emerges as key priority, along with jobs, supply chain resilience and patient benefits
With
Justin Foster,
Associate Director, Advocacy and Government Relations,
Medical Technology Association of Australia
Brendan Cummins
VP & General Manager ANZ,
Baxter Healthcare
The Hon Courtney Houssos MLC, Minister for Finance,
Minister for Domestic Manufacturing and Government Procurement,
Minister for Natural Resources, NSW Parliament
James Doyle, Vice-Chair
Medical Technology Association of Australia (MTAA)
Lachlan Thorpe, Age 21
Diagnosed with CRPS following sporting injury, recipient of spinal cord stimulator
SEGMENT
Filmed in Sydney | August 2026
The inaugural NSW Parliament MedTech Showcase, hosted by The Hon Courtney Houssos MLC has highlighted the medical technology sector’s contribution to patient care, local manufacturing, jobs and the broader economy.
Speaking with the Australian Health Journal, Justin Foster, Associate Director of Advocacy and Government Relations at the Medical Technology Association of Australia (MTAA), said the event provided an important opportunity for industry and government to work together on shared priorities.
He said the showcase demonstrated that MedTech not only saves and improves lives, but also creates significant economic opportunities through manufacturing, investment, exports and employment. “We’re collaborating with them on a unity ticket in terms of delivering more value to the economy, manufacturing, and also to local jobs,” Foster said.
The event brought together a diverse range of companies, from emerging startups and small and medium-sized businesses to global MedTech companies investing in NSW. The showcase also demonstrated the importance of sovereign manufacturing capability, particularly during supply disruptions.
The message was local production could strengthen supply chains while supporting highly skilled employment and innovation. The event also provided an opportunity for the industry to discuss policy issues, including value-based procurement, which seeks to ensure purchasing decisions consider the broader value of medical technologies rather than price alone.
Foster said the showcase could serve as a model for further engagement across Australia. “There is definitely an opportunity for us to be engaging across states and territories,” with future discussions potentially extending the initiative beyond NSW.
Source: Written by Australian Health Journal from transcript.
-
Family biz succeeds in vaccine approval & distribution
It’s been 10 years since Jenny and Karl Herz started in business. Over the past 10 years they’ve launched Biointelect and Biocelect businesses to help secure approval and distribution for new medicines into Australia.
In this Australian Health Journal interview, Jenny and Karl talk about the journey the husband and wife team took to get the Novavax COVID-19 vaccine (Nuvaxovid) approved and distributed in Australia. The journey didn’t just include talented and diverse skilled staff but also their children working in both organisations.
-
Elevating Professional Standards in the Medtech and Pharmaceutical Sector
ARCS Australia Ltd, the peak body representing professionals in the MedTech and Pharmaceutical sector, this week announced a series of significant changes at its annual conference.
Dr Tim Boyle, CEO of ARCS Australia Ltd speaking to Australian Health Journal says, “These initiatives are central to strategy to build professionalism within the sector, increase capability and enhance the professional standing of its members.”
-
Investigating use of dietary supplements for osteoarthritis
Osteoarthritis is a leading cause of disability affecting over 2 million Australians, according to Australian Institute of Health and Welfare report on Chronic musculoskeletal conditions (2024) and 595 million people globally, according to BD 2021 Osteoarthritis Collaborators. Global, regional, and national burden of osteoarthritis, 1990–2020. It represents a significant public health burden that diminishes quality of life among ageing populations.
